TrialA Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
Trial details
- Registry ID
- NCT04762069
- Phase
- Phase 2
CNSP
CNS Pharmaceuticals, Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
1Trials in this database
3Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma MultiformeNCT04762069 | CNSP | Phase 2 | Active not recruiting | 2026-04-27Estimated |
Latest recorded trial changes
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
NCT04762069 · CNS Pharmaceuticals, Inc.
Participant count type changed
− Before
Estimated
+ After
Actual
Enrollment · participant count changed
− Before
210 participants (planned)
+ After
252 participants (actual)
Primary completion date changed
− Before
1 Feb 2026
+ After
27 Apr 2026